Buphthalmos is an eye condition where one or both eyes look enlarged in infancy or early childhood. It happens most often due to high eye pressure from congenital glaucoma, and features can include light sensitivity, tearing, and a cloudy-looking cornea. Many people first hear about Buphthalmos when a baby’s eyes seem larger than expected in photos or during a routine check. It is lifelong, but early surgery and pressure-lowering treatments can protect vision and reduce complications. Most children with timely care do well, but delayed treatment can lead to vision loss, so prompt evaluation by a pediatric eye specialist is important.
Overview
BuphthalmosSymptoms
Buphthalmos shows as an unusually large eye in a baby, often with cloudy front surface, tearing, and strong light sensitivity. Caregivers may notice frequent blinking or eye rubbing, irritability, and possible vision problems; clinicians often find high eye pressure.
Outlook and prognosis
Many living with Buphthalmos do well when it’s identified and treated early, especially if pressure is lowered promptly. Vision outcomes vary: some keep near-normal sight, while others develop glaucoma-related damage. Ongoing eye care and timely surgeries often preserve useful vision.
Causes and risk factors
Buphthalmos usually stems from high eye pressure in infancy due to primary congenital glaucoma; rarer causes include secondary glaucoma from developmental eye anomalies or certain syndromes. Risk increases with family history, consanguinity, and specific genetic variants; lifestyle factors are minimal.
Genetic influences
Genetics plays a major role in Buphthalmos, often linked to inherited forms of childhood glaucoma. Variants in genes affecting eye fluid drainage can raise risk. Family history matters; genetic counseling and testing may guide screening for siblings and future pregnancies.
Diagnosis
Diagnosis of Buphthalmos relies on clinical features—an enlarged, cloudy cornea and increased eye size—confirmed with eye pressure measurement and imaging. Examination under anesthesia is common in infants. Genetic tests may help when congenital glaucoma is suspected.
Treatment and drugs
Treatment for buphthalmos focuses on lowering eye pressure early to protect vision. Doctors often start with pressure‑reducing eye drops, then move to procedures like laser or surgery to improve fluid drainage. Ongoing follow‑up, protective eyewear, and vision support are key.
Symptoms
Parents may spot one or both eyes looking unusually large or growing faster than expected. Buphthalmos is most often seen in infancy, and many families notice the early features of Buphthalmos during everyday moments like taking photos or bath time. Loved ones often notice the changes first. These features can make bright light uncomfortable and may affect how vision develops.
One or both eyes look bigger than expected for age. The change may be subtle at first or more obvious in Buphthalmos. Photos can make the size difference easier to spot.
One eye appears larger than the other. In Buphthalmos, this asymmetry can develop over weeks to months. Families often notice it when looking straight at the face.
The clear front of the eye looks hazy or bluish-gray. In medical terms, this is corneal swelling; in everyday life, it shows up as a cloudy front window that dulls the eye’s sparkle. The cloudiness can shift during the day.
Bright light causes discomfort, squinting, or crying. Clinicians call this photophobia, which means light makes the eyes feel sore or irritated. Hats or sunglasses may help in the short term.
How people usually first notice Buphthalmos?
Parents and pediatricians often first notice buphthalmos in infancy when one or both eyes look unusually large, especially compared with the face, sometimes with a cloudy-looking cornea. Babies may be very sensitive to light, tear excessively, or keep their eyes closed, and a doctor may detect high eye pressure or an enlarged corneal diameter during an exam. These first signs of buphthalmos usually prompt urgent referral to an eye specialist to evaluate for congenital glaucoma and protect vision.
Types of Buphthalmos
Buphthalmos can look and feel different depending on when it starts and how much the eye’s drainage system is affected. It usually reflects pressure-related stretching of the eye in early life, so types of buphthalmos are often tied to age at onset and whether it occurs alone or with other eye findings. People may notice different sets of symptoms depending on their situation. Across types, common signs include enlarged, cloudy-looking eyes, light sensitivity, tearing, and changes in vision that can shift over time.
Isolated congenital
The eye is enlarged due to high pressure present from birth or early infancy. Symptoms often include big appearing eyes, light sensitivity, tearing, and vision blur. Early treatment aims to protect the optic nerve and support visual development.
Infantile onset
Enlargement appears after the newborn period, typically within the first year. Families may notice one eye looking bigger, with frequent tearing and squinting in bright light. Vision may fluctuate as pressure changes day to day.
Late toddler onset
Signs emerge around ages 2–3, with a less dramatic eye size difference but ongoing pressure-related changes. Children may rub the eyes, avoid light, or sit very close to screens. Even within the same type, intensity can range from mild to severe.
With corneal changes
The enlarged eye also shows corneal clouding or surface breaks that make the eye look hazy. This type often brings strong light sensitivity and variable vision. Scarring can affect clarity even after pressure is controlled.
With optic nerve impact
The main concern is damage to the nerve that carries visual signals. Vision may drop, peripheral sight can shrink, and contrast sensitivity can fade. Care focuses on lowering pressure and protecting remaining vision.
Associated syndromic
Buphthalmos occurs alongside known genetic syndromes or other eye differences. Symptoms can be more varied, and growth or developmental needs may shape care choices. Loved ones may recognize certain types sooner than the person experiencing them.
What genetics can tell you about symptoms
Some babies with CYP1B1 gene changes develop early, enlarged, bulging eyes and tearing because fluid can’t drain well, raising eye pressure. Variants in LTBP2 or TEK can cause similar swelling, light sensitivity, and corneal clouding, often signaling primary congenital glaucoma.
Causes and risk factors
Buphthalmos usually happens when pressure in a baby’s eye rises because the eye’s drain did not form correctly before birth. Some risks are written in our DNA, passed down through families. It can also occur without family history due to a new gene change or as part of rare eye development syndromes. Known risk factors for buphthalmos include a family history of early glaucoma, being male, and having parents who are closely related by blood. Lifestyle or environmental exposures are not known to cause buphthalmos, and there are no habits that clearly change your risk.
Environmental and biological risk factors
Understanding what can raise the chance of Buphthalmos helps families and clinicians focus on early checks and support. Doctors often group risks into internal (biological) and external (environmental). Below are the environmental risk factors for Buphthalmos and the key biological influences most closely tied to it.
When the eye’s fluid outflow area doesn’t form normally before birth, pressure can rise soon after. That early pressure makes Buphthalmos more likely in the first months of life.
Certain conditions present at birth that change the front of the eye or its blood vessels can raise early eye pressure. These structural differences increase the likelihood of Buphthalmos.
Buphthalmos occurs somewhat more often in infants born male. The reason for this pattern is not fully understood.
Infections during pregnancy such as rubella can disrupt eye development. This can increase the risk of infant glaucoma and Buphthalmos.
Genetic risk factors
Genetic changes that affect how the eye’s drainage system forms can lead to buphthalmos, most often through primary congenital glaucoma. Several genes—most notably CYP1B1—have been linked to these early-life cases, though the exact gene can differ by family and ancestry. Risk is not destiny—it varies widely between individuals. Families may first notice early symptoms of buphthalmos in the first months of life, and understanding the underlying gene can guide testing of relatives.
CYP1B1 variants: Changes in the CYP1B1 gene are the most common known genetic cause of primary congenital glaucoma worldwide. When this gene does not work as expected, the eye’s outflow channels may not form properly, raising eye pressure and leading to buphthalmos. Symptoms can appear in early infancy.
LTBP2 variants: Faults in the LTBP2 gene can cause severe early glaucoma in some families. This gene helps scaffold the front of the eye, and changes can disrupt normal drainage development.
TEK/ANGPT1 pathway: Variants in TEK (also called TIE2) and occasionally in ANGPT1 alter signals that guide the growth of the eye’s drainage vessels. These changes can produce primary congenital glaucoma and, in some families, buphthalmos. Some TEK variants act in a dominant way, so a single altered copy may be enough.
FOXC1 variants: Extra or missing copies, or changes within FOXC1, can shift how the front of the eye forms. This can be part of an anterior segment condition with early glaucoma. Eye doctors may see distinctive features on exam even when symptoms are subtle.
PITX2 variants: Changes in PITX2 can cause anterior segment differences that raise eye pressure early in life. Glaucoma in this setting can be severe and may require early treatment.
PAX6 (aniridia): Alterations in PAX6 can lead to aniridia and a high risk of childhood glaucoma. When pressure rises early, the enlarging eye can progress to buphthalmos.
Autosomal recessive pattern: In many families, primary congenital glaucoma follows a recessive pattern, meaning a child is affected if both parents carry the same gene change. Parents are usually healthy carriers but still have a chance of another child with the condition.
Ancestry-linked variants: Certain CYP1B1 or LTBP2 changes are more frequent in specific ancestries due to founder effects. Knowing family origins can help doctors prioritize which genes to test first when buphthalmos is suspected.
Parental relatedness: Parents who are related or share close ancestry have a higher chance of carrying the same rare recessive variant. This increases the likelihood of recessive conditions such as buphthalmos in children.
Variable penetrance: Even within the same family, a gene change can lead to different ages of onset and severity. Some relatives may have early glaucoma, while others have only mild signs or none at all.
New (de novo) changes: Sometimes the gene change arises for the first time in the child and is not found in either parent. These new variants can still disrupt eye development and cause early glaucoma.
Lifestyle risk factors
Buphthalmos develops from abnormal eye pressure early in life; everyday habits do not cause it. However, certain lifestyle choices can influence pressure fluctuations, symptoms like photophobia and tearing, and risks of corneal injury or postoperative complications. Understanding how lifestyle affects Buphthalmos helps families reduce discomfort and protect the eye over time.
Frequent rubbing can worsen corneal stretching and scarring in an already enlarged, fragile eye. Reducing rubbing lowers the risk of infection and may limit worsening astigmatism.
Inverted positions and prolonged bending can raise intraocular pressure (IOP). Limiting head‑down time may help protect the optic nerve and reduce corneal stress.
Forceful Valsalva maneuvers from heavy lifting or constipation can spike IOP. Using proper lifting technique and maintaining soft stools (fiber, fluids) may blunt pressure surges.
Moderate aerobic activity can modestly lower IOP and support ocular blood flow. Avoid high‑impact or contact activities without eye protection to reduce trauma risk.
Risk prevention
Buphthalmos usually happens when high pressure in a baby’s eye stretches the eye, most often from congenital glaucoma. You can’t fully prevent it, but early detection and rapid treatment can protect vision and lower the chance of long-term damage. Knowing your risks can guide which preventive steps matter most.
If close relatives have congenital glaucoma or unusually large eyes, consider genetic counseling to understand the chance of buphthalmos in future children. Counseling can also discuss testing options and family planning.
Newborn and infant eye exams can catch enlarged corneas, light sensitivity, and tearing before lasting damage occurs. Ask for prompt evaluation if you notice early symptoms of buphthalmos like a hazy, growing eye.
If buphthalmos is suspected, a same-week visit with a pediatric eye specialist helps control eye pressure quickly. Early surgery or pressure-lowering drops can limit stretching and protect vision.
Avoid steroid eye drops in infants unless prescribed and closely monitored, as they can raise eye pressure. Always confirm any eye medicine with a pediatric eye doctor.
Transmission
Buphthalmos is not contagious; you can’t catch it or pass it to someone else. It usually starts before birth and is often tied to congenital glaucoma, where fluid doesn’t drain well from the eye and pressure stretches the still-flexible eye tissues. In some families, buphthalmos relates to gene changes inherited in an autosomal recessive way—both parents carry a silent copy and a child who inherits both can be affected—this explains the genetic transmission of Buphthalmos in certain families. It can also appear with no family history if a new gene change occurs for the first time, and some children with buphthalmos have no identifiable genetic cause. If you’re worried about how Buphthalmos is inherited or future pregnancy risks, a genetics professional can review your family history and discuss testing options.
When to test your genes
Buphthalmos is present at birth or early infancy, so genetic testing is considered when the eye is abnormally enlarged, glaucoma is suspected, or there’s a family history of early-onset glaucoma. Testing can confirm inherited forms, guide surveillance for the other eye, and inform care for siblings. Ask a pediatric ophthalmologist or genetic counselor.
Diagnosis
You might notice small changes in daily routines, like a baby turning away from light, tearing more than expected, or one eye looking unusually large or cloudy. For many families, these early symptoms of Buphthalmos prompt an urgent eye check. Early and accurate diagnosis can help you plan ahead with confidence. In most cases, the diagnosis of Buphthalmos is based on the eye’s appearance and pressure measurements, then confirmed with specialized exams by a pediatric eye specialist.
An eye doctor looks for an enlarged, often hazy cornea and increased eye size compared to age norms. They also note light sensitivity, tearing, and eyelid squeezing typical of infant eye irritation.
The clear front window of the eye is measured to check if the corneal diameter is larger than expected for age. Marked enlargement supports Buphthalmos over other causes.
Gentle tonometry is used to measure intraocular pressure. Higher-than-normal pressure in an infant raises concern for glaucoma causing Buphthalmos.
The doctor examines the optic nerve for cupping or thinning that suggests pressure-related damage. This helps gauge severity and urgency of treatment.
Stages of Buphthalmos
Buphthalmos does not have defined progression stages. It’s a physical change from high eye pressure early in life; enlargement can increase if pressure isn’t controlled, but severity is described by measurements rather than by stages. An eye specialist checks eye pressure, the optic nerve, and measures corneal size—values over about 12 mm (1.2 cm, ~0.5 in) in infants raise concern—and may do an exam under anesthesia; early symptoms of buphthalmos can include tearing and light sensitivity. Different tests may be suggested to help confirm the cause and guide treatment.
Outlook and prognosis
Families often want to know how life will change after a baby is diagnosed with buphthalmos, especially when early symptoms of buphthalmos—like light sensitivity, tearing, or an enlarged, cloudy-looking eye—raise urgent questions. The condition is serious because it usually signals high pressure inside the eye in infancy, which can damage the optic nerve and affect vision. Early care can make a real difference, and prompt treatment to lower eye pressure can preserve sight that might otherwise be lost. Mortality is not increased by buphthalmos itself; the main concern is vision, including the risk of permanent vision loss if pressure stays high for too long.
Looking at the long-term picture can be helpful. With timely surgery and ongoing eye-drop therapy when needed, many children with buphthalmos maintain useful vision in at least one eye and grow up to attend regular schools. Some may still have reduced sharpness of vision, uneven focus, or a wandering eye, and glasses, patches, or vision therapy are often part of care. Regular follow-up is essential because eye pressure can creep up again as a child grows, and the cornea and optic nerve need repeated checks over the years.
Everyone’s journey looks a little different. Some children need more than one surgery, while for others a single procedure plus drops keeps pressure controlled for a long time. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle; when buphthalmos is linked to inherited forms of childhood glaucoma, the risk of pressure returning can be higher, and siblings may be offered screening. Talk with your doctor about what your personal outlook might look like, including how often to schedule eye exams and what signs—like increased light sensitivity or eye enlargement—should prompt a sooner visit.
Long-term effects
Buphthalmos can leave lasting effects on eye structure and vision, especially when pressure changes begin in infancy. Outcomes often depend on how early the eye was affected and how the optic nerve and cornea developed over time. Long-term effects vary widely, and many living with buphthalmos have a mix of stable traits and areas that change slowly. Some notice that early symptoms of buphthalmos fade, while subtle vision changes become more noticeable with age.
Pressure-related injury can narrow side (peripheral) vision over time. In advanced cases, central vision can also be affected.
A large, sometimes cloudy cornea may persist, with fine cracks (Haab striae) or scarring. This can cause glare and light sensitivity.
The enlarged eye often leads to high short-sightedness and astigmatism. Vision can stay blurry without correction.
Unequal or unclear vision during childhood can disrupt visual development. This can leave one eye with lasting reduced vision.
How is it to live with Buphthalmos?
Living with buphthalmos often means navigating vision differences and frequent eye care from an early age. Many children need regular visits for pressure checks, eye drops or oral medications, and sometimes surgery, which can affect family routines and school schedules; light sensitivity and enlarged eyes may also draw attention, so gentle support at home and in class helps. For caregivers, learning to spot signs of rising eye pressure—more tearing, irritability in bright light, eye rubbing—can be stressful, but having a clear plan with the eye team makes day-to-day decisions easier. With consistent follow-up and practical accommodations like sunglasses, hats, and extra time for visual tasks, many grow into daily rhythms that protect vision and keep life active and connected.
Treatment and drugs
Treatment for buphthalmos focuses on lowering eye pressure early to protect vision and the optic nerve. Although living with buphthalmos can feel overwhelming, many people manage their symptoms and live fulfilling lives. Eye surgeons often start with pressure-lowering eye drops and medicines by mouth; however, surgery is the mainstay because enlarged eyes in infants and young children usually need a procedure to open the eye’s natural drainage or create a new pathway for fluid to leave. Common operations include goniotomy or trabeculotomy in early disease, and trabeculectomy or glaucoma drainage implants if pressure remains high; a doctor may adjust your dose to balance benefits and side effects when medicines are used before or after surgery. Regular follow-up with measurements of eye pressure, cornea clarity, and optic nerve health—plus prompt treatment of complications like corneal swelling or infection—is essential to protect sight over time.
Non-drug treatment
For infants and children with buphthalmos, care without medicines focuses on safely lowering eye pressure and protecting how vision develops over time. Non-drug treatments often lay the foundation for vision health while surgery addresses the pressure problem. Options range from eye procedures to day‑to‑day strategies that shield the eyes and support visual development. Noticing early symptoms of buphthalmos—like light sensitivity and tearing—can help families seek timely care and plan supportive therapies.
Surgeons open the eye’s natural drain to lower pressure. This is usually done under general anesthesia and can be repeated if needed. If one method doesn’t help, there are usually other options.
A tiny tube can be placed to carry fluid out of the eye and reduce pressure. This may be considered when angle surgery is not enough.
Targeted laser energy can reduce the fluid made in the eye or improve outflow. It is sometimes used when other procedures are less suitable.
Shatter-resistant glasses or a soft shield can help prevent injuries to an enlarged, more delicate eye. Family members often play a role in supporting new routines like wearing protective eyewear.
Your genes may have an impact on how drugs work for you
Some medicines used for people with buphthalmos, like pressure‑lowering eye drops or anesthesia during procedures, can work differently depending on genes that affect drug processing and target response. Genetic differences may change dose needs or side‑effect risk, guiding more personalized care.
Pharmacological treatments
Medicines can help lower eye pressure in buphthalmos, most often as a bridge to surgery or alongside it. Treatments aim to protect the optic nerve and relieve pressure that causes early symptoms of buphthalmos like tearing and light sensitivity. Not everyone responds to the same medication in the same way. Your eye team will tailor choices to your child’s age, safety needs, and how urgent the pressure control is.
Timolol eye drops can lower pressure by reducing fluid production in the eye. They are often used short-term or with other drugs, but can slow the heart or breathing in infants, so careful monitoring is needed.
Dorzolamide or brinzolamide drops reduce fluid production and can be used with beta-blockers. Acetazolamide by mouth is sometimes used briefly for stronger pressure control, with possible tiredness, stomach upset, or changes in blood salts.
Latanoprost or travoprost can increase fluid outflow, though results in congenital glaucoma are mixed. They may darken the iris or grow eyelashes, and are usually add-on therapies rather than first choice in infants.
Brimonidine is generally avoided in young children due to risks of extreme sleepiness and breathing problems; apraclonidine may be used short-term with supervision. These drugs reduce fluid production but safety limits their role in infants.
Genetic influences
Genetics can play a role when buphthalmos develops in infancy because the eye’s drainage system didn’t form as expected. Family history is one of the strongest clues to a genetic influence. In some families, the pattern is recessive, meaning both parents quietly carry a gene change and there’s a 25% (1 in 4) chance in each pregnancy of a child being affected; in others, there’s no known family history because the change is new in the child. Gene changes that affect the eye’s fluid outflow can raise pressure early in life, but severity can differ widely, even between siblings. When early symptoms of buphthalmos appear in more than one relative, doctors may suggest genetic counseling and testing to clarify the cause, plan care, and estimate risks for future pregnancies. Buphthalmos can also be part of a broader eye difference or syndrome, so finding a genetic cause can help tailor monitoring for related issues.
Is Buphthalmos genetic?
Genetics plays a major role in Buphthalmos, often linked to inherited forms of childhood glaucoma. Variants in genes affecting eye fluid drainage can raise risk. Family history matters; genetic counseling and testing may guide screening for siblings and future pregnancies.
Pharmacogenetics—how genetics influence drug effects
For most children, treatment of buphthalmos centers on surgery to improve fluid drainage, with pressure‑lowering eye drops used before and after procedures. Genes can influence how quickly you break down some glaucoma medicines, especially beta‑blocker drops like timolol, so the same dose may be stronger for one child than another. Children who naturally clear timolol more slowly can have higher drug levels in the bloodstream, which raises the risk of slow heart rate, low blood pressure, or breathing issues; in these cases, doctors may use the lowest effective dose, a gel drop, pressing on the tear duct after dosing, or a different class of medication. By contrast, children who clear the drug quickly may get less pressure lowering from a standard dose and need a different medicine or earlier surgery. In families with known gene changes linked to primary congenital glaucoma, buphthalmos often starts earlier and can be more severe, which guides timing of surgery and how closely the eyes are monitored. Pharmacogenetic testing is not routine in buphthalmos, but when side effects or poor response occur, it can be worth asking whether genetics should inform the choice or dose of pressure‑lowering drops.
Interactions with other conditions
In early childhood, high pressure inside the eye can overlap with other eye and medical issues. Buphthalmos often travels with conditions that affect eye development, including Sturge‑Weber syndrome, Axenfeld‑Rieger syndrome, aniridia, or neurofibromatosis, because these can be linked to the type of glaucoma that enlarges the eye. Ask if any medications for one condition might interfere with treatment for another. For example, steroid creams, inhalers, or drops used for allergies, asthma, or skin rashes can raise eye pressure and may worsen buphthalmos, while some glaucoma drops can aggravate wheezing or slow the heart. Buphthalmos can also interact with strabismus and amblyopia: blurred vision from corneal swelling or large refractive errors can make a “lazy eye” more likely, so patching or glasses may be needed alongside pressure control. When another disorder is present, early symptoms of Buphthalmos—light sensitivity, tearing, or a cloudy looking cornea—can be harder to spot, making regular eye checks with shared care between specialists especially important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants with unusually large, strikingly clear eyes that seemed sensitive to light and watered easily. Family stories sometimes recalled a baby who squinted in daylight and kept the eyelids tightly shut; doctors later recognized these early symptoms of Buphthalmos, an eye condition linked to high pressure inside the eye in early life.
First described in the medical literature as an enlargement of the eye in infancy, Buphthalmos was initially understood only through what could be seen at the bedside: a big, rounded eye, a cloudy or hazy front surface, and tearing. In the 19th and early 20th centuries, physicians connected these signs to raised eye pressure and used the broader term “congenital glaucoma” when the drainage system of the eye did not form normally. Over time, descriptions became more precise, separating true enlargement of the eye from other causes of a large-looking eye, such as shallow sockets or eyelid differences.
As medical science evolved, hand-held instruments allowed doctors to measure eye pressure and examine the front of the eye in infants more safely. This shifted Buphthalmos from a purely visual diagnosis to one grounded in measurable findings. By the mid-20th century, surgeons developed techniques to open or reshape the eye’s drainage pathways in babies, which improved outcomes and helped cement the link between Buphthalmos and pressure-related damage to the optic nerve.
Advances in genetics later clarified that not all Buphthalmos is the same. Some families showed inherited patterns, and certain gene changes were tied to abnormal development of the eye’s drainage angle before birth. These discoveries explained why some babies developed severe enlargement within weeks, while others showed milder changes over months. They also highlighted differences across populations and helped guide counseling for future pregnancies.
In recent decades, awareness has grown that early diagnosis and specialist care can protect vision. New imaging, gentler anesthesia, and refined surgical approaches have reduced complications. At the same time, careful historical review led to clearer definitions: Buphthalmos refers specifically to enlargement of the eyeball from elevated pressure in early life, usually within the first three years, distinguishing it from conditions that only mimic a large eye.
Looking back helps explain today’s approach: watchfulness for light sensitivity, tearing, and rapid changes in eye size; prompt pressure checks; and timely surgery when needed. The history of Buphthalmos traces a path from bedside observation to precise measurement and genetic insight, each step improving the chances that children can see more clearly as they grow.